Medicament for treating colonitis

Abstract

The invention discloses a medicament for treating colonitis, which is prepared from the following bulk drugs by weight: 200 portions of calcite (calcined), 40 portions of halitum (calcined), 400 portions of clematis aethusifolia (calcined), 400 portions of rhododendron micranthum (calcined), 5 portions of nutmeg, 5 portions of coriander fruit, 5 portions of rhizoma zingiberis, 5 portions of long pepper, 5 portions of dwarf lilyturf root, 1 portion of pepper, 5 portions of dried white turnip, 5 portions of sal ammoniac, 5 portions of purple sal ammoniac, 5 portions of elecampane, and 10 portions of potassium nitrate. The formulation is a pure Chinese medicament preparation, has small toxic side effect, is suitable for the characteristic of chronic colonitis recurrent attacks, can be taken for a long time, and has remarkable curative effect; besides the formulation adopts a dosage form of enteric-coated granules to avoid the first pass effect in stomach absorption and act on affected parts directly, and each medicinal material in the formulation adopts the principle of relieving diarrhea with astringents and treating both principal and secondary aspects of a disease to achieve the aim of treatment, thus the medicament for treating colonitis is surely a classic anaesthetic worthy of development in clinical application.

Description

technical field

[0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating colitis. Background technique

[0002] At present, colitis is a disease that mainly invades the rectal and colon mucosa, often forms erosions and ulcers, with diarrhea, abdominal pain, pus and blood in the stool as the main symptoms, and diffuse non-specific inflammation of the large intestine. The disease mostly involves the rectum and distal colon, and then develops to the proximal end, and even affects the entire colon. For the treatment of colitis at home and abroad, western medicine mostly adopts parenteral nutrition, antibiotics, hormones, immunosuppression and surgical treatment. Currently developed new oral or enema 5-aminosalicylic acid preparations can achieve therapeutic effects, but the cost is high and expensive. Contents of the invention

[0003] The purpose of the present invention is to provide a medicine for treat...